2 completed, 1 recruiting. 1 Not applicable, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 1 | Completed 1 |
| Phase 2 | 1 | Recruiting 1 |
Follow Yu Wang: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Physical Activity Promoting Active Aging Mind-body exercise, Multicomponent exercise, Online-based multicomponent exercise - Active Aging Individuals Aged 60 and Over | Not applicable | Completed | Yu Wang | 100 | 2025-03-01 | 2026-10-14 |
| Donafenib Combined With Anti-PD-1 Antibody for Neoadjuvant Therapy in Locally Advanced Thyroid Cancer Donafeib with Sintilimab - Thyroid Cancer | Phase 2 | Recruiting | Yu Wang | 14 | 2024-07-24 | 2025-01-22 |
| Clinical Observation of Hysteroscopy-Assisted Placement of Handmade Frameless GyneFix-LNG-IUS (Retrospective Cohort) Handmade Frameless GyneFix-LNG-IUS - Intrauterine Device Expulsion, Adenomyosis, Endometriosis | Completed | Yu Wang | 15 | 2024-02-01 | 2026-04-08 |
Adenomyosis (1) · Dysmenorrhea (1) · Endometriosis (1) · Menorrhagia (1) · Metrorrhagia (1) · Thyroid Neoplasms (1)
sintilimab (1)
China (3)